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High-resolution Imaging of 
Myeloperoxidase Activity Sensors 
in Human Cerebrovascular Disease
Youssef Z. Wadghiri1, Dung Minh Hoang1, Anita Leporati2, Matthew J. Gounis2, Aurora 
Rodríguez-Rodríguez3, Mary L. Mazzanti2, John P. Weaver4, Ajay K. Wakhloo2, Peter Caravan  3 
& Alexei A. Bogdanov Jr  2
Progress in clinical development of magnetic resonance imaging (MRI) substrate-sensors of enzymatic 
activity has been slow partly due to the lack of human efficacy data. We report here a strategy that 
may serve as a shortcut from bench to bedside. We tested ultra high-resolution 7T MRI (µMRI) of 
human surgical histology sections in a 3-year IRB approved, HIPAA compliant study of surgically 
clipped brain aneurysms. µMRI was used for assessing the efficacy of MRI substrate-sensors that detect 
myeloperoxidase activity in inflammation. The efficacy of Gd-5HT-DOTAGA, a novel myeloperoxidase 
(MPO) imaging agent synthesized by using a highly stable gadolinium (III) chelate was tested both in 
tissue-like phantoms and in human samples. After treating histology sections with paramagnetic MPO 
substrate-sensors we observed relaxation time shortening and MPO activity-dependent MR signal 
enhancement. An increase of normalized MR signal generated by ultra-short echo time MR sequences 
was corroborated by MPO activity visualization by using a fluorescent MPO substrate. The results of 
µMRI of MPO activity associated with aneurysmal pathology and immunohistochemistry demonstrated 
active involvement of neutrophils and neutrophil NETs as a result of pro-inflammatory signalling in the 
vascular wall and in the perivascular space of brain aneurysms.
Magnetic resonance imaging (MRI) provides 3-D structural information about tissue volume as well as detailed 
physiological and anatomical information for thick tissue sections. Ultra-high-resolution MRI using small 
field-of-view acquisitions, i.e. micro-MRI (µMRI), can be used to obtain microscopic images within whole 
organs (e.g. MRI biopsy) reflecting differences in water relaxation times in various tissue components1. Such 
µMRI techniques have been used to study the developmental biology of mice2,3, reveal details of brain structure4,5, 
and show anatomical and functional changes of skeletal/connective tissue systems6,7. Moreover, development 
of specially designed radiofrequency coils has further allowed µMRI of sub-millimetre thick microscopic tissue 
sections8,9. Both non-specific10 and pathology-specific MR contrast agents5 have been evaluated for their ability 
to produce images with highly delineation of target areas and their compatibility with standard histology mark-
ers. However, the utility of µMRI as a surrogate for high-resolution contrast-assisted in vivo MR imaging has 
not been fully explored. Using animal models of human disease, we and others previously demonstrated that 
paramagnetic substrate-sensors of neutrophil myeloperoxidase (MPO) activity11,12 are highly useful in imaging 
inflammation-linked pathologies of the cardiovascular system13–15 and brain16,17. Generation of MPO-specific 
MR contrast is brought about via the enzymatic oxidation of MPO-reducing hydroxytryptamides. These para-
magnetic hydroxytryptamides are small molecules, which undergo various oxidative transformations ultimately 
leading to the formation of dimers, oligomers and protein-bound forms12,18. Covalent binding to proteins results 
in the retention of paramagnetic chelated metals on cell surfaces and components of the extracellular matrix19,20, 
Fig. 1A. Here we report the utility of µMRI for detecting MPO activity in inflammatory lesions within the vascu-
lar wall of excised human brain aneurysms (hBA) and arteriovenous malformations (AVM). By combining µMRI 
with fluorescent probe-mediated imaging of MPO activity (Fig. 1B) and immunohistochemical corroboration we 
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set forth to find out: (1) whether µMRI of enzyme- dependent vascular wall enhancement is feasible in the very 
small volumes of histology sections and; (2) whether such MR signal enhancement correlates with the distribu-
tion of MPO activity in the tissue.
Results
Histology of human tissue samples. The initial immunohistochemistry of unruptured hBA samples 
obtained as a result of surgical clipping revealed multiple IL-8 (CXCL8) cytokine positive cells infiltrating the 
vascular wall both along the adventitial and luminal sides of hBA (Fig. 2A,C). Ineterleukin-6-positive cells were 
present as sparse infiltrates detectable only on the adventitial side of the vessels (Fig. 2B) while MCP-1 (CCL2) 
antigen was not detectable in any of the samples we tested. Smooth muscle cells in hyperplastic thickened areas 
of aneurysmal wall showed a strong activation of NF-kB with nuclei of cells binding an antibody against pho-
sopho-p65 in all unruptured aneurysmal samples we processed (Fig. 2C).
As determined by our interdisciplinary cerebrovascular interventional imaging team, immunohistochemis-
try and immunofluorescent detection of specific neutrophil enzymatic markers in tissue sections demonstrated 
that regardless of hBA location, all unruptured hBA contained neutrophil-specific antigens, i.e. myeloperoxidase 
(Fig. 3A–D) and elastase (Fig. 3D,F). Both enzymes could potentially be used as tracking markers of neutrophils. 
We observed the presence of intracellular and extracellular neutrophil MPO antigen in the majority of samples 
of clipped brain aneurysms. Neutrophils were localized primarily around the lumen after infiltrating into the 
vascular wall (Fig. 3B–D), as well as within the walls of the adventitial neovessels21,22. Intracellular neutrophil 
elastase was also present and could be identified by using a single or dual staining (alongside with anti-MPO 
antibody, Fig. 3D,F). The vessel wall-infiltrated neutrophils showed more prominent anti-elastase staining than 
more peripheral MPO-positive neutrophils attached to the surface of the aneurysms (Fig. 3D). In the subluminal 
regions of the vessel walls we observed the formation of perivascular wall haemorrhages and neutrophil extracel-
lular traps (NETs) suggesting terminal neutrophil activation in the areas of vascular pathology and microthrom-
bosis (Fig. 3B, arrow). Furthermore, by using a fluorescent MPO substrate 5HT-Cy3 (5-hydroxytryptamide of the 
cyanine dye Cy3, a red fluorophore) we were able to perform visualization of MPO activity in surgical samples. 
The assessment of MPO activity as opposed to the presence of protein antigen alone was essential for determin-
ing whether it would be feasible to further process the samples for µMRI because MR signal depended on the 
presence of active MPO enzyme. Activation of 5HT-Cy3 by MPO results in production of reactive species that 
link to nearby molecules of which a substantial fraction are proteins of extracellular matrix and fibrin of thrombi. 
By incubating frozen sections with 5HT-Cy3 in the presence of hydrogen peroxide we observed MPO activity 
as bright red fluorescent signal associated with the cells infiltrating human AVM and hBA samples (Fig. 4A–C). 
It should be noted that in the majority of processed human samples, MPO activity was positively identified in 
polymorphonuclear cells as well as extracellular deposits (Fig. 4C) suggesting the stability of extracellular enzyme 
resulting in preservation of enzyme activity. These cells had irregular shaped nuclei and were present in both 
unruptured hBA and AVM surgical samples. The cells stained positively not only for MPO activity with 5HT-Cy3 
probe, but also expressed S100 calcium-binding proteins characteristic of granulocytes and some other leukocytes 
(Fig. 4D,E).
Figure 1. MPO-mediated reactions of imaging probes resulting in imaging signal. (A) Membrane-associated 
myeloperoxidase (MPO) dimer converts soluble paramagnetic substrates into the immobilized products 
which increase paramagnetic MR signal. Hydrogen peroxide is generated in the blood vessel wall as a result 
of superoxide anion dismutation. MPO is using hydrogen peroxide and Gd-5HT-DOTAGA (shown as an 
example) to generate oxidized products at protoporphyrin IX MPO catalytic sites. These products bind 
to nearby proteins. (B) Chemical formulas of Gd-5HT-DOTAGA and 5HT-Cy3. The simplified reaction 
mechanism between the hydroxytryptamide probes (R = Gd-DOTAGA or Cy3) and the oxidized form of MPO 
is shown below. The intermediates (free radicals) react with the proteins at tyrosine residues (pathway 1) or 
undergo dimerization/oligomerization (pathway 2)19,49.
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Figure 2. Immunohistochemistry of pro-inflammatory marker expression in a representative unruptured hBA. 
Immunoperoxidase detection of the following antibodies: (A) anti-IL8; (B) anti-IL6; (C) anti-MCP-1; (D) anti-
NF-kB phospho p65. The sections were counterstained with H & E. Arrows point to cytokine- positive cells in 
panels A and B. Magnification – 20x.
Figure 3. Immunohistochemistry and immunofluorescence of clipped human unruptured hBA (thin frozen 
sections). (A) (magnification – 10x), (B) (magnification – 40x) – hBA, yellow arrow points to MPO-positive 
NETs in the lumen, bar = 100 µm, anti-MPO staining with anti-human MPO monoclonal antibody (alkaline 
phosphatase-labelled secondary anti-mouse mAb); (C) hBA (magnification – 20x), anti- MPO staining. 
(D) hBA dual staining of infiltrated periluminal neutrophils with anti-MPO (red fluorescence) and anti-
elastase (green fluorescence) antibodies, 20x; (E) hBA, anti-MPO staining, 20x; (F) hBA anti-elastase (green 
fluorescence) staining. In panels A, B, C, and E the nuclei are counterstained with nuclear fast red. In D and F 
nuclei are stained with DAPI (blue).
www.nature.com/scientificreports/
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Testing MPO substrates in vitro. To achieve MPO-specific µMRI imaging in histology sections we used 
two types of substrate-sensors: (1) Gd-bis-5HT-DTPA that was previously used by multiple research groups for 
imaging of MPO activity in vitro and in vivo14–16 (2) novel MR imaging sensor Gd-5HT-DOTAGA. All tested 
MPO imaging sensors function as electron donors, which is an essential property required to reduce oxidized 
MPO to a catalytically active state. Initially we tested both substrates in parallel to investigate whether the sub-
stitution of the acyclic DTPA chelate for a macrocyclic DOTAGA results in the expected increase of stability and 
thus resistance to trans-metallation, i.e. the release of paramagnetic Gd(III) from the chelate in the presence 
of an excess of competing biologically relevant ions such as Zn(II) and phosphate. As we anticipated, in trans-
metallation test Gd-5HT-DOTAGA showed no statistically significant decrease of relaxation rate R1 (p > 0.05). 
A decrease in R1 would signify a conversion into insoluble form and disappearance of Gd(III) from the solvating 
water environment. In contrast, Gd-bis-5-HT-DTPA showed a time-dependent decrease of the initial R1 values 
consistent with the lower stability of this MPO substrate-sensor (i.e. greater propensity for trans-metallation, see 
Supplementary Figure S1A).
We further tested whether the MPO-mediated catalysis reaction leads to a conversion of both macrocyclic 
and acyclic linear Gd(III) chelating substrates into products with higher Gd(III) molar relaxivity, which under-
lie the enhancement of MR signal in T1-weighted images. The effects of MPO reaction on the relaxivity of the 
initial substrates were analysed at three different field strengths. At low magnetic field strength (0.47T, 20 MHz) 
Figure 4. Fluorescence microscopy of MPO activity. The images show 5HT-Cy3 staining of MPO – positive 
cells. 5HT-Cy3 (red fluorescence) detects the presence of active MPO enzyme. (A) The infiltration of MPO+ 
neutrophils from the vascular lumen of human unruptured hBA; (B) MPO in cells infiltrated in AVM 
(magnification – 10x); (C) AVM sample showing intracellular and extracellular MPO at high magnification 
(40x), L- vascular lumen; (D) high-magnification image of infiltrating neutrophils in unruptured hBA (see 
panel A) by using MPO and anti-calprotectin (S100A8/A9 complex) detection (63x); (E) - high-magnification 
image of infiltrating neutrophils in AVM (see panel C) by using MPO and calprotectin detection. Red- 5HT-
Cy3, green - anti-calprotectin antibody, blue - DAPI. Bars (D,E) = 25 µm.
www.nature.com/scientificreports/
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we observed the expected increase of molar longitudinal relaxivities of Gd(III) (r1, Figure S2). Both substrates 
(Gd-bis-5HT-DTPA and Gd-5HT-DOTAGA) resulted in a similar, approximately 1.5–1.7 fold increase of molar 
transverse relaxivity after MPO and hydrogen peroxide were added to reaction mixtures (Figure S1B). The 
increase was even more pronounced in the case of Gd-5HT-DOTAGA/MPO reactions run in the presence of 
human serum albumin (2.5-fold increase of longitudinal relaxivity) while Gd-bis-5HT-DTPA showed a lower 
relative increase. An increase of r1 due to MPO-catalysed reaction of Gd-5HT-DOTAGA was also seen at the 
higher clinical field strength of 1.4T. Unlike the measurements performed at lower magnetic field strengths (i.e. 
0.47 and 1.5T), the measurements performed at 7T did not show any detectable Gd(III) relaxivity change when 
MPO reaction products were compared to the initial substrate (Figure S1B). Measurements of T2 and T2* of 
Gd-5HT-DOTAGA products of the reaction with MPO pointed to a strong increase of transverse relaxation 
effects, i.e. a sharp increase of r2/r1 ratio when compared to low field/lower resonance frequency environments.
Micro-MRI and histology corroboration. The verification of MPO activity in human tissue sections by a 
fluorescent 5HT-Cy3 substrate (Fig. 4) and subsequent testing of paramagnetic tryptamides (Figure S1) suggested 
the feasibility of detecting MPO paramagnetic substrate-sensors in human tissue using µMRI histology. We first 
validated the sensitivity of our µMRI system by performing parallel fluorescent and MR imaging of specially 
designed tissue-like phantoms. These phantoms were designed to obtain a model tissue containing MPO within 
thick and thin histological sections. Phantoms were made by moulding standard MPO solutions with known 
specific activity and concentration into separate cylindrically shaped gels by adding a polyacrylamide-stabilized 
Matrigel/agarose matrix. This approach (1) enabled imaging of samples containing various concentrations of 
MPO simultaneously, (2) allowed diffusion of MPO substrate-sensors into the matrix of phantom sections during 
co-incubations; (3) allowed testing of various MPO substrate-sensors simultaneously and (4) allowed measure-
ment of water relaxation times after subsequent retention of MPO reaction products in the matrix of phantom 
sections. The range of MPO concentrations tested was chosen to emulate the range previously measured by our 
group in surgical samples of human aneurysmal tissue, i.e. approximately 200 U of MPO activity per mg-tissue 
in MPO-positive aneurysms21. Measurements of fluorescence intensity demonstrated that the average fluores-
cence intensity of MPO sample sections increased in order of increasing concentrations of MPO in the matrix 
(Fig. 5A,B); r1 and r2 molar relaxivities along with mean MR signal intensities were measured following 7T µMR 
acquisitions of embedded MPO samples. Results showed a near-linear correlation of MR R1 and R2 relaxation 
rate values (r2 = 0.76–0.78, p = 0.04–0.05) with increasing MPO concentrations (0.1–1.0 U MPO/µl) in section 
volumes of the phantom (Fig. 5C,D) and demonstrated the sensitivity of our µMRI imaging system.
Next, by using the same µMRI acquisition set up we set out to investigate the utility and sensitivity of µMRI for 
the detection of inflammation in human brain tissue as evidenced by the presence of MPO activity and neutrophil 
infiltration in human brain tissue. Initially we performed imaging of sections prepared from a sample of human 
brain arteriovenous malformation (AVM) because it provided a larger sample volume and thus better coil-filling 
factor, which enables faster image acquisition and optimization (Fig. 6). Despite the endogenous bright contrast 
due to white matter present in the field of view, the imaging of AVM showed the presence of enhancement around 
the irregular vascular luminae (shown by arrows, Fig. 6A). This pattern of T1w-SE sequence generated signal 
Figure 5. Fluorescence and 7T µMRI imaging of a tissue-like phantom. Phantom consisted of 5 wells 
containing thick (100 µm) frozen sections of tissue-like material containing various specific enzymatic activity 
of MPO (well 1 = 0, well 2 = 0.1, well 3 = 0.2, well 4 = 0.6 and well 5 = 1.0 U MPO/µl). MPO was dissolved and 
embedded in agarose/acrylamide/Matrigel mixture. (A) Phantom appearance, the colour is due to phenol red 
in the Matrigel samples 1–5 immersed in OCT medium; (B) fluorescence microscopy of thin sections of the 
phantom in A treated with 0.1 mM 5HT-Cy3/1 mM H2O2 after removing of unreacted 5HT-Cy3; (C) µMR 
imaging of the phantom after incubating 0.1 mm-thick sections in the presence and 0.5 mM bis-5HT-Gd-
DTPA/1 mM H2O2 (UTE pulse sequence acquisition, with image inversion); (D) Relaxation rates R1 and R2 
(measured by using µMRI of thick sections) as a function of MPO concentration in the phantom components. 
Data shown as mean ± SD (n = 3).
www.nature.com/scientificreports/
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enhancement (Fig. 6A), which correlated with the areas that were strongly reactive with anti-MPO antibody on 
histology sections (Fig. 6B).
A total of two ruptured and six unruptured hBA were further subjected to imaging with µMR after obtaining 
50–80 µm sections (Figs 7 and 8). An ultrashort TE (UTE) pulse sequence was chosen to decrease the T2* effects 
at 7T that interfered with Gd-mediated longitudinal water relaxation time shortening (Fig. 7A). In a relatively 
large hBA (Fig. 7).
Figure 6. µMR Imaging and correlative immunohistochemistry of human arteriovenous malformation and 
unruptured human aneurysm. (A) µMRI image of a thick section (80 µm) of the arteriovenous malformation 
(AVM) showing moderate to strong T1-weighted signal detected over the circumference of the structures 3 
and 4; (B) matching section showing immunohistochemical (IHC) detection of MPO (blue); (C) µMRI image 
of a left middle cerebral artery unruptured human aneurysm tissue sample; (D) a light microscopy image of 
thick section shown in panel C; (E) an anti-MPO IHC image (thin section). MPO positive cells (blue, 20x 
magnification) are pointed to by an arrow (inset). (F) Red fluorescence of MPO+ cells and extracellular MPO. 
Anti-MPO staining was performed by treating the tissue sequentially with anti-MPO mAb (anti-human mouse 
monoclonal antibody (1:200, AbCam), followed by a secondary mAb-alkaline phosphatase conjugate (1:500, 
Roche.). Yellow arrow is pointing to the area matched to the inset of panel (E, black arrow). This area is positive 
by MPO immunofluorescence (E) and MPO activity (F). Bar = 50 µm. In B and C the counterstaining of nuclei 
was performed by using Nuclear Fast Red (Vector labs) and DAPI was used for image F. MPO activity was 
revealed by incubating the section in the presence of 0.1 mM 5HT-Cy3/1 mM H2O2 for 30 min.
www.nature.com/scientificreports/
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we observed two major areas of MR signal enhancement, which correlated with the presence of adventitial 
angiogenesis (Fig. 7, asterisk) and luminal micro haemorrhage (Fig. 7, arrows), both of which contained MPO 
activity as confirmed by using a fluorescent substrate of MPO (Fig. 7C). Overall, the same trend was observed 
in the samples of ruptured as well as unruptured hBA. In general, fluorescent substrate localized in tissue areas 
containing MPO activity which matched very well with the areas of elevated MR signal determined by applying 
UTE pulse sequence or T1w-SE pulse sequences (Figs 7 and 8). Due to the extensive infiltration of neutrophils 
and NETs in the luminal clots, the MPO activity was easily detectable in the samples of ruptured hBA (Fig. 8). 
For example, the matrix of the clot appeared bright on T1w images (Fig. 8A) after treating with paramagnetic 
MPO substrate-sensor. The same area showed MPO activity resulting in red fluorescence after incubating with 
5HT-Cy3, and the level of fluorescence decreased dramatically after adding the irreversible inhibitor of MPO 
(Fig. 8G).
Discussion
In this study, we used a µMRI histology setup for determining the distribution of MPO, a molecular marker of 
active inflammation within the microarchitecture of very small surgically excised fragments of hBA. Molecular 
imaging of this essential enzyme’s catalytic activity has been made possible by linking of an MR detectable par-
amagnetic metal (chelated Gd(III) to a substrate of the MPO enzyme (5HT). Upon diffusion into the tissue, the 
Gd(III)-conjugated 5HT substrate is oxidized by MPO, and is then retained at the site primarily as a result of 
binding to proteins. As a result, the areas with higher water relaxation rates are generated within the areas of high 
MPO activity. Two versions of chelated Gd(III) conjugated to 5HT were tested in this study: an acyclic DTPA 
chelate (Gd-bis-5HT-DTPA) and a macrocyclic DOTA chelate (Gd-5HT-DOTAGA). The distinction between 
linear and macrocyclic Gd(III) chelates is clinically significant owing to the higher safety profile of macrocyclic 
formulations23,24. Gd-5HT-DOTAGA demonstrated a higher MPO-mediated molar longitudinal relaxivity (r1) 
increase due to a lower initial relaxivity of non-reacted Gd-5HT-DOTAGA at 0.47–1.4T. The differences between 
the relaxivities of non-modified versus MPO-oxidized Gd-5HT-DOTAGA substrate-sensor are what give rise to 
the changes in MR signal intensity between pre- and post-contrast µMRI images and thus the potential clinical 
utility of this MPO sensor.
We anticipated that testing of MPO substrate-sensors at clinically relevant (1.5 and 3T) field strengths 
would eventually be needed to obtain a clearer picture of how compounds will perform in a more standard 
clinical setting. The higher field strength of 7T has some advantages for MR imaging, i.e. the overall higher tis-
sue signal-to-noise ratio essential for the imaging of extremely small histology sections. High-field MRI also 
presents obstacles such as the increase in the ratio of r2/r1 compared to lower field strengths, which results in 
lower post-contrast signal enhancement for a given dose of Gd(III)-based MRI contrast agent. Those limitations 
can be partially overcome with optimization of pulse sequences such an ultrashort echo time (UTE) sequence, 
which maximizes signal from tissues with exceedingly short transverse relaxation times. Other factors must 
also be considered in interpreting µMR imaging results acquired in this study. Since the thickness of sections 
intended for µMRI exceeded standard histology section thickness by a factor of 10, the registration of the two 
image sets is not always 1:1 and this imposes limitations on the interpretation of signal overlap between the two 
visualization modalities. However, this does not prevent registering of µMR images with fluorescence images of 
MPO activity distribution in the tissue (Fig. 7). Results presented here and obtained in hBA imaging using MPO 
substrate-sensors confirmed previous results showing positive correlation between normalized MPO enzymatic 
activity localized in aneurysmal microstructure, and the presence of neutrophil infiltration as determined by 
immunohistochemistry and vascular wall inflammation/hBA instability21,25,26. The presence of MPO activity in 
the blood of patients, mainly as a component of neutrophil NETs27 brought about by the cells of innate immune 
Figure 7. Comparison of µMRI of large unruptured hBA with the results of histology and fluorescence 
microscopy. (A) MRI (UTE pulse sequence) of a thick section of hBA treated with Gd-bis-5HT-DTPA 
and imaged by using µMRI coil; (B) trichrome stain of a consecutive thin section, magnification -10x; 
C- fluorescence microscopy of a thick section stained by using fluorescent MPO reducing substrate 5HT-
Cy3, magnification -4x. Scale bar = 1 mm. Arrowheads point to the area of thrombus containing infiltrated 
neutrophils and MPO. Asterisks indicate the location of adventitial vessel (evidence of adventitial angiogenesis), 
containing MPO-positive cells.
www.nature.com/scientificreports/
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system is a known indicator of downstream acute vascular events including strokes28 and the increased risk of 
aneurysm rupture within a 5-year period21.
Cerebral aneurysms are characterized histologically by chronic inflammation and degenerative changes to the 
vessel wall which may contribute to aneurysm pathogenesis and rupture29–32. Numerous inflammatory cytokines 
such as interleukins33,34, monocyte chemoattractant protein 1 (MCP1)35,36, as well as activation of NF-kB30,37 have 
been shown mechanistically to contribute to the pathogenesis of cerebral aneurysms. The picture emerging from 
results presented here, as well as numerous studies obtained in animal models and humans, shows the pathology 
of aneurysm development and rupture is complex and that multiple signalling cascades occurring in a range 
of vascular cell types and the extracellular matrix are involved (reviewed in38). Vascular wall remodelling may 
occur early in response to chronic vascular wall stress resulting from haemodynamic abnormalities. Ensuing 
endothelial damage may trigger the up-regulation of transcription factor NF-kB in smooth muscle cells and 
recruitment of inflammatory cells releasing IL-1β, IL-8, TNFα and other pro-inflammatory mediators39,40. We 
confirmed the presence of many IL-8-positive cells that infiltrate hBA wall potentially in response to downstream 
signalling associated with NF-kB activation (Fig. 2). Interleukin-8 (CXCL8) is a potent neutrophil chemotactic 
factor41 additionally promoting angiogenesis suggesting active participation of neutrophils in aneurysmal wall 
remodelling42. The demonstrated use of µMRI for the detection of MPO activity in situ in non-fixed human 
tissue sections has applicability to the ever-increasing number of investigations that seek to understand the role 
of molecular and nanoparticle-assisted imaging in detecting the development and progression of brain vascular 
pathology22,43. The potential of µMRI as a preclinical and translational imaging modality is promising but is still 
in the early stages of being fully validated. However, we anticipate that high-resolution µMRI has a potential of 
becoming widely applicable in the development of new tissue-specific contrast agents and sensors involving direct 
interaction with the components of surgically excised human tissue samples. We foresee broad application of this 
technique in research directed at testing specific activity of novel MR enzyme-specific substrates in realistic in 
vitro model systems.
Methods
This prospective study involving human pathology samples was approved by the University of Massachusetts 
Medical School (UMMS) Institutional Review Board (IRB) and patient’s written informed consent was required 
before surgery. HIPAA compliance was enforced throughout the study. The following inclusion criteria were 
applied: included were adult female and male patients (ages 18–79 years old) with symptomatic or asymptomatic, 
ruptured or unruptured saccular cerebral artery aneurysms for which microsurgical clipping has been deemed 
the most appropriate course of treatment. The following exclusion criteria were applied: traumatic or mycotic 
aneurysms, aneurysms in patients with concurrent adult polycystic kidney disease, aneurysms in patients with 
concurrent degenerative connective tissue disorders including cystic medial necrosis, fibromuscular dysplasia, 
Marfan syndrome, Turner’s syndrome, and giant cell and Takayasu’s arteritis, patients within a vulnerable popu-
lation, including foetuses, neonates, pregnant women, patients unable to provide informed consent, institution-
alized individuals and prisoners. A total of n = 10 surgically resected samples of human saccular aneurysms were 
included in the study (n = 7 female, n = 3 male, 2 ruptured, 8 unruptured, median age - 57 years; see Table 1). One 
Figure 8. µMR Imaging and histology of ruptured hBA: (A) a T1w µMRI image of a thick section (80 µm) 
of ruptured hBA showing an area of strong enhancement in the dome of the aneurysm marked by an arrow; 
(B) T2w image of the same area; (C) light microscopy; (D) T1w µMRI image of vascular wall fragments in the 
same sample; (E) T1w µMRI of a section consecutive to (D) incubated with MPO paramagnetic substrate and 
0.5 mM MPO inhibitor 4-aminobenzoichydrazide (4-ABH); (F) fluorescence microscopy image of a section 
corresponding to area on image (A) shown by the arrow after treating with 0.1 mM 5HT-Cy3/1 mM H2O2 to 
reveal MPO activity; (G) same as (F) but performed in the presence of MPO inhibitor 4-ABH, bar = 50 µm; H- 
anti-MPO antibody staining of a thin section. Bar = 200 µm Magnification – 20x (F,G), 10x (H).
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frozen sample of AVM (sectioned) was generously provided by Drs. William L. Young and Hua Su (William L. 
Young, M.D., Department of Anesthesia and Perioperative Care, University of California, San Francisco).
Myeloperoxidase substrate synthesis and testing. Fluorescent substrate 5HT-Cy3, (5-hydroxytryptamide 
of Cy3) was synthesized by using a method described in 44. Briefly, 5HT-Cy3 was synthesized by reacting 1.1 molar 
excess of 5-hydroxytryptamine with mono N-hydroxysuccinimide ester of Cy3 (GE Healthcare Bios-Sciences Corp., 
Piscataway NJ) in DMF in the presence of triethylamine under argon. The reaction product was precipitated using 10 
volumes of acetone:diethyl ether (1:2 by vol), dried under argon and purified by using C18 HPLC (Discovery C18 col-
umn, Sigma, St. Louis MO) and a gradient of acetonitrile in 0.05 M triethylammonium acetate, pH 7.0.
Sodium salt of Gd-5HT-DOTAGA (gadolinium(III)-mono-5-hydroxytryptamide of 2,2′,2′′-(10-(2,6-dioxotet
rahydro-2H-pyran-3-yl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetic acid) was synthesized in three steps: 
(1) the coupling of tert-butyl protected DOTAGA45 with serotonin hydrochloride by using the HATU coupling 
reagent and DIPEA as a base; (2) acidic deprotection with formic acid and hydrochloric acid of the protecting 
groups; (3) complex formation with Gd(III) by using gadolinium chloride in a sodium acetate buffer at pH 6. 
The purification was performed by using fast liquid chromatography on C18-reversed phase (ISCO CombiFlash) 
by using a gradient of acetonitrile in 0.1% formic acid with subsequent characterization by mass-spectrometry, 
(Agilent LCMS 6130) and gadolinium (III) content by inductively coupled plasma-mass spectrometry (Agilent 
ICP-QQQ 8800).
Gadolinium (III) DTPA bis-5-hydroxytryptamide (Gd-bis-5HT-DTPA) was synthesized and character-
ized as described in12,46. All substrates were purified using C18-HPLC and lyophilized prior to use. Test reac-
tions in the presence of 6.6 U MPO (1100 U/mg, Meridian Life Sci, Memphis TN) and 1.2 U glucose oxidase 
(Millipore-Sigma, St. Louis MO) and various concentrations of MPO substrates were run for 3–18 h and subjected 
to analysis using relaxometry at 0.47T and 1.41T (Minispec mq20 and mq60, Bruker BioSpin Corp. Billerica MA) 
and gel electrophoresis as described in13,47.
Histology. hBA and AVM surgical samples were obtained immediately post resection and were immersed in 
sterile saline. All hBA samples used in the study (n = 10) are listed in Table 1. Thin frozen sections (6–8 µm thick) 
were fixed in acetone (−20 °C). After washing in 50 mM Tris, 100 mM NaCl (TBS) aneurysm and AVM sample 
sections were incubated for 90 min in TBS containing 1 mM EDTA, pH 7 at 60 °C to inhibit endogenous phos-
phatase activity and blocked in 5% bovine serum in TBS, pH 7.5 for 2 h. Anti-human MPO mouse monoclonal 
antibodies (2C7), anti-calprotectin (S100A8/A9 complex) antibody (MAC387), Polyclonal rabbit anti-p65 NF-kB 
antibody (ab86299), anti- IL-6 mAb (ab9324), anti-IL-8 mAb (ab18672) all from Abcam, Cambridge MA, were 
incubated with the sections overnight at 1:200–1:300 dilutions in 5% bovine serum in TBS. The secondary anti-
body (anti-mouse rabbit- alkaline phosphatase conjugate, Roche) was used at 1:500 dilution. For identification of 
neutrophil extracellular traps (NETs) rabbit polyconal anti-histone H3 antibody (citrulline R2 + R8 + R17, ab5103 
Abcam) was covalently modified by using N-hydroxysuccinimide ester of digoxigenin carboxylic acid (Roche 
Diagnostics, Indianapolis, IN) and purified on Bio-Spin P30 spin columns (Bio-Rad, Hercules CA) as described 
in48. Anti-digoxigenin F(ab′)2 alkaline phosphatase conjugate (Roche) at dilution 1:400 was used to identify 
digoxigenin-labeled primary antibodies. The staining was performed using a nitro-blue tetrazolium and 5-bromo-
4-chloro-3′-indolyphosphate (NBT/BCIP) solution (Roche Applied Science) and counter-stained with nuclear fast 
red. Serial thick (80–100 µm) non-consecutive sections were subjected to µMRI imaging following incubation with 
0.5 mM Gd-5HT-DOTAGA and 1 mM hydrogen peroxide for 30 min. Fluorescent staining of MPO-positive cells 
and staining of extracellular MPO in thin sections was performed by incubating the sections in the presence of 
0.1 mM 5HT-Cy3/1 mM H2O2 with DAPI counterstaining of the nuclei. In control experiments specific irreversible 
inhibitor of MPO 4-aminobenzoic acid hydrazide was added to the substrate solution at 1 mM.
Patient 
number Age Sex Location(a) UR/R
Largest 
diameter, mm µMRI
Immunohistochemistry markers
MPO NETs(b) calprotectin(c)
1 50 M RMCA R 11 + + ND +
2 71 F RMCA R 11 + + ND +
3 39 F LMCA UR 8 + + ND −
4 71 F RMCA UR 6 + + + +
5 62 F LMCA UR 9 − + − +
6 76 M LMCA UR 6 − + + +
7 51 F ACOM UR 3 − + + −
8 52 F LMCA UR 7 + + + +
9 52 F RMCA UR 4 + + + +
10 74 M ACOM UR 8 − − + +
Table 1. Characteristics of surgically obtained aneurysmal dome samples. (a)RMCA- Right middle cerebral 
artery; LMCA- left middle cerebral artery; ACOM - anterior communicating artery; UR- unruptured, R- 
ruptured. (b)Neutrophil extracellular traps (NETs) were detected by using digoxigenin-labeled anti-histone 
H3 (citrulline R2 + R8 + R17) antibody, (ab5103 Abcam). (c)S100 calcium-binding proteins (expressed by 
granulocytes, monocytes and macrophages) were detected by using anti-calprotectin (S100A8/A9 complex) 
antibody (ab22506, Abcam); ND- not done.
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MR microscopy. Thick sections of human brain vascular pathology specimens (Table 1, 80–100 µm thick) 
were treated as above in the presence of MPO imaging substrates (0.5 mM in PBS) for 30 minutes in the absence 
or in the presence of MPO inhibitors before being imaged with µMRI using a T1w-SE sequence. Direct µMRI of 
tissue sections was performed using a set of homebuilt histological coils tuned to operate at the Larmor frequency 
corresponding to 300 MHz and interfaced to a 200 mm horizontal bore 7 Tesla Bruker µMRI system (Bruker 
BioSpin) equipped with an actively shielded gradient coil insert 750-mT/m gradient strength, 100-μs rise time9. 
Depending on the sample (40-µm to 100-µm) and the histology coil used, the MRI in-plane spatial resolution 
ranged from 57-µm to 100-µm acquired within the overnight scan. Pulse sequences used: 2D T1w-GE with TE/
TR 3.2/100 ms; 2D multi-echo T2*w-GE TE/ES/TR 4.9/4.2/100 ms.
Statistics. Statistical analysis was performed by using Prism 7 (GraphPad Software Inc.) Results are expressed 
as mean ± SD. The analysis of means and assignment of statistical significance was be performed by using 
two-tailed unpaired t-test with Welch’s correction.
Data availability. All data generated or analysed during this study are included in this published article (and 
its Supplementary Information files).
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